Comparison of hemodynamic stress response in controlled hypertensive patients between MacIntosh Direct Laryngoscope and Hugemed VL3R video laryngoscope

Hemodynamic Stress Response In Controlled Hypertensive Patients : A Randomized Comparison Of Hugemed VL3R Video Laryngoscope And Macintosh Laryngoscope - NIL

Status

Active, not recruiting

Phases

Phase 4

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2024/04/065565

Enrollment

Registered

2024-04-12

Start date

Unknown

Completion date

Unknown

Last updated

2024-04-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: I10- Essential (primary) hypertension Health Condition 2: I10- Essential (primary) hypertension

Interventions

Intervention1: Hugemed VL3R Video Laryngoscope: Intubation response in hypertensive patients to laryngoscopy for endotracheal intubation as measured by Heart rate , Blood pressure at 0 minute , 1 minu

Eligibility

Inclusion criteria

Inclusion criteria: American Society of Anesthesiologists (ASA) physical status classification II , controlled hypertensive patients.Patients with valid informed consent.

Exclusion criteria

Exclusion criteria: Patient refusal to participate in the study. Patients with other co-morbidities. Pregnant Patients. BMI >30kg/m2 Patients with anticipated difficult airway

Design outcomes

Primary

Measure	Time frame
To assess the hemodynamic stress response to endo-tracheal intubationTimepoint: heart rate systolic diastolic & mean arterial blood pressure at 1 minute 2 minute 3 minute 5 minute & 10 minute after intubation	—

Secondary

Measure	Time frame
ease of endo-tracheal intubation,number of attempts & duration of intubation.Timepoint: at the time of intubation	—

Countries

India

Contacts

Public ContactDr Swarnamba U N

Karnataka Institute Of Medical sciences hubballi

drswarnmba@rediffmail.com9448559776

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026